NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









StradBio, Inc.

StradBio, Inc.

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://stradbio.com/

Last Round

Accelerator

Jul 7, 2025

Company Overview

StradBio, Inc. is a biotechnology company that develops engineered cytokine-based immunotherapies for the treatment of cancer and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

cytokine immunotherapycomputational protein designde novo protein designprotein engineeringlogic-gated activationin silico drug discoverybiotech platformprecision medicinedrug discovery platformtherapeutic indexAI drug discoveryin silico biologycomputational biologybiotech startupprotein design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StradBio, Inc. Comparables

Compare StradBio, Inc. with similar companies based on industry and business-model similarity.

StradBio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Soteria Biotherapeutics
82%
Bright Peak Therapeutics
77%
Asher Biotherapeutics
75%

StradBio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 7, 2025

StradBio, Inc. Investors

Notable investors and investment history

StradBio, Inc. investors
InvestorRounds
University of Toronto Asset Management CorporationAccelerator
Creative Destruction LabAccelerator

StradBio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

StradBio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StradBio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range2
Year Founded2023
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.